These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 20601184)

  • 21. The immune response and maternal antibody interference to a heterologous H1N1 swine influenza virus infection following vaccination.
    Kitikoon P; Nilubol D; Erickson BJ; Janke BH; Hoover TC; Sornsen SA; Thacker EL
    Vet Immunol Immunopathol; 2006 Aug; 112(3-4):117-28. PubMed ID: 16621020
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cross-protection against influenza virus infection by intranasal administration of M2-based vaccine with chitosan as an adjuvant.
    Sui Z; Chen Q; Wu R; Zhang H; Zheng M; Wang H; Chen Z
    Arch Virol; 2010 Apr; 155(4):535-44. PubMed ID: 20195654
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of the virulent influenza virus infection by oral formulation of nonhydrolized carnosine and isopeptide of carnosine attenuating proinflammatory cytokine-induced nitric oxide production.
    Babizhayev MA; Deyev AI
    Am J Ther; 2012 Jan; 19(1):e25-47. PubMed ID: 20841992
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical experience with OM-85 BV in upper and lower respiratory tract infections.
    Derenne JP; Delclaux B
    Respiration; 1992; 59 Suppl 3():28-31. PubMed ID: 1439237
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Seasonal FluMist vaccination induces cross-reactive T cell immunity against H1N1 (2009) influenza and secondary bacterial infections.
    Sun K; Ye J; Perez DR; Metzger DW
    J Immunol; 2011 Jan; 186(2):987-93. PubMed ID: 21160043
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral administration of a Spirulina extract enriched for Braun-type lipoproteins protects mice against influenza A (H1N1) virus infection.
    Pugh ND; Edwall D; Lindmark L; Kousoulas KG; Iyer AV; Haron MH; Pasco DS
    Phytomedicine; 2015 Feb; 22(2):271-6. PubMed ID: 25765832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo study on the immunomodulating effects of OM-85 BV on survival, inflammatory cell recruitment and bacterial clearance in Klebsiella pneumonia.
    Broug-Holub E; Kraal G
    Int J Immunopharmacol; 1997; 19(9-10):559-64. PubMed ID: 9637354
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence that a primary anti-viral stimulation of the immune response by OM-85 reduces susceptibility to a secondary respiratory bacterial infection in mice.
    Rossi GA; Bessler W; Ballarini S; Pasquali C
    Ital J Pediatr; 2018 Sep; 44(1):112. PubMed ID: 30257691
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cross-protection against influenza virus infection by intranasal administration of M1-based vaccine with chitosan as an adjuvant.
    Sui Z; Chen Q; Fang F; Zheng M; Chen Z
    Vaccine; 2010 Nov; 28(48):7690-8. PubMed ID: 20870054
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of Clinacanthus siamensis leaf extract on influenza virus infection.
    Wirotesangthong M; Nagai T; Yamada H; Amnuoypol S; Mungmee C
    Microbiol Immunol; 2009 Feb; 53(2):66-74. PubMed ID: 19291089
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Eurocine L3 adjuvants with subunit influenza antigens induce protective immunity in mice after intranasal vaccination.
    Petersson P; Hedenskog M; Alves D; Brytting M; Schröder U; Linde A; Lundkvist A
    Vaccine; 2010 Sep; 28(39):6491-7. PubMed ID: 20637767
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bacterial extract OM-85 BV protects mice against experimental chronic rhinosinusitis.
    Tao Y; Yuan T; Li X; Yang S; Zhang F; Shi L
    Int J Clin Exp Pathol; 2015; 8(6):6800-6. PubMed ID: 26261565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protective efficacy of an H1N1 cold-adapted live vaccine against the 2009 pandemic H1N1, seasonal H1N1, and H5N1 influenza viruses in mice.
    Shi J; Wen Z; Guo J; Zhang Y; Deng G; Shu Y; Wang D; Jiang Y; Kawaoka Y; Bu Z; Chen H
    Antiviral Res; 2012 Mar; 93(3):346-53. PubMed ID: 22281419
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protection of mice against lethal infection with highly pathogenic H7N7 influenza A virus by using a recombinant low-pathogenicity vaccine strain.
    de Wit E; Munster VJ; Spronken MI; Bestebroer TM; Baas C; Beyer WE; Rimmelzwaan GF; Osterhaus AD; Fouchier RA
    J Virol; 2005 Oct; 79(19):12401-7. PubMed ID: 16160167
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heterosubtypic immunity to influenza mediated by liposome adjuvanted H5N1 recombinant protein vaccines.
    Thueng-in K; Maneewatch S; Srimanote P; Songserm T; Tapchaisri P; Sookrung N; Tongtawe P; Channarong S; Chaicumpa W
    Vaccine; 2010 Sep; 28(41):6765-77. PubMed ID: 20688037
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intranasal administration of a flagellin-adjuvanted inactivated influenza vaccine enhances mucosal immune responses to protect mice against lethal infection.
    Hong SH; Byun YH; Nguyen CT; Kim SY; Seong BL; Park S; Woo GJ; Yoon Y; Koh JT; Fujihashi K; Rhee JH; Lee SE
    Vaccine; 2012 Jan; 30(2):466-74. PubMed ID: 22051136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Macrophage activation by OM-85 BV.
    Mauël J
    Respiration; 1992; 59 Suppl 3():14-8. PubMed ID: 1332156
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bacterial cell wall components as immunomodulators--II. The bacterial cell wall extract OM-85 BV as unspecific activator, immunogen and adjuvant in mice.
    Bessler WG; Huber M; Baier W
    Int J Immunopharmacol; 1997; 19(9-10):551-8. PubMed ID: 9637353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. OM-85 BV upregulates the expression of adhesion molecules on phagocytes through a CD 14-independent pathway.
    Marchant A; Goldman M
    Int J Immunopharmacol; 1996 Apr; 18(4):259-62. PubMed ID: 8894805
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bacterial immunostimulants--mechanism of action and clinical application in respiratory diseases.
    Rozy A; Chorostowska-Wynimko J
    Pneumonol Alergol Pol; 2008; 76(5):353-9. PubMed ID: 19003766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.